Related Experiment Video
Updated: Jul 11, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Diversity of penicillin-binding proteins. Resistance factor FmtA of Staphylococcus aureus
Xin Fan1, Yuhong Liu, Daryl Smith
1Department of Chemistry, York University, Toronto, Ontario M3J 1P3, Canada.
Abstract:
Antibiotic-resistant Staphylococcus aureus is a major concern to public health. Methicillin-resistant S. aureus strains are completely resistant to all beta-lactams antibiotics. One of the main factors involved in methicillin resistance in S. aureus is the penicillin-binding protein, PBP2a. This protein is insensitive to inactivation by beta-lactam antibiotics such as methicillin. Although other proteins are implicated in high and homogeneous levels of methicillin resistance, the functions of these other proteins remain elusive. Herein, we report for the first time on the putative function of one of these proteins, FmtA. This protein specifically interacts with beta-lactam antibiotics forming covalently bound complexes. The serine residue present in the sequence motif Ser-X-X-Lys (which is conserved among penicillin-binding proteins and beta-lactamases) is the active-site nucleophile during the formation of acyl-enzyme species. FmtA has a low binding affinity for beta-lactams, and it experiences a slow acylation rate, suggesting that this protein is intrinsically resistant to beta-lactam inactivation. We found that FmtA undergoes conformational changes in presence of beta-lactams that may be essential to the beta-lactam resistance mechanism. FmtA binds to peptidoglycan in vitro. Our findings suggest that FmtA is a penicillin-binding protein, and as such, it may compensate for suppressed peptidoglycan biosynthesis under beta-lactam induced cell wall stress conditions.
Insights
FmtA, a protein in methicillin-resistant Staphylococcus aureus, interacts with beta-lactam antibiotics. This interaction suggests FmtA may be a penicillin-binding protein crucial for antibiotic resistance.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Resistance
Background:
- Antibiotic-resistant Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA), poses a significant public health threat.
- Penicillin-binding protein 2a (PBP2a) is a key factor in MRSA's resistance to beta-lactam antibiotics.
- The roles of other proteins contributing to high-level MRSA resistance remain largely unknown.
Purpose of the Study:
- To investigate the function of the FmtA protein in methicillin resistance in Staphylococcus aureus.
- To elucidate the mechanism by which FmtA interacts with beta-lactam antibiotics.
Main Methods:
- Biochemical assays to study the interaction between FmtA and beta-lactam antibiotics.
- Analysis of the active-site serine residue and its role in complex formation.
- Investigation of FmtA's binding affinity and acylation rate with beta-lactams.
- Conformational change studies of FmtA in the presence of beta-lactams.
- In vitro binding assays of FmtA to peptidoglycan.
Main Results:
- FmtA forms covalently bound complexes with beta-lactam antibiotics.
- A conserved serine residue in FmtA acts as the active-site nucleophile.
- FmtA exhibits low binding affinity and slow acylation rates for beta-lactams, indicating intrinsic resistance.
- Beta-lactam exposure induces conformational changes in FmtA.
- FmtA demonstrates binding to peptidoglycan in vitro.
Conclusions:
- FmtA is identified as a putative penicillin-binding protein.
- FmtA's properties suggest it contributes to intrinsic beta-lactam resistance.
- FmtA may play a role in compensating for peptidoglycan biosynthesis under cell wall stress induced by beta-lactams.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Staphylococcal Skin Infections
Inhibitors of Gram-positive Cell Wall Synthesis
